These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 15198530)

  • 1. Effect of degree of esterification of pectin and calcium amount on drug release from pectin-based matrix tablets.
    Sungthongjeen S; Sriamornsak P; Pitaksuteepong T; Somsiri A; Puttipipatkhachorn S
    AAPS PharmSciTech; 2004 Feb; 5(1):E9. PubMed ID: 15198530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biphasic release of indomethacin from HPMC/pectin/calcium matrix tablet: II. Influencing variables, stability and pharmacokinetics in dogs.
    Wu B; Deng D; Lu Y; Wu W
    Eur J Pharm Biopharm; 2008 May; 69(1):294-302. PubMed ID: 17988844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pectin/anhydrous dibasic calcium phosphate matrix tablets for in vitro controlled release of water-soluble drug.
    Mamani PL; Ruiz-Caro R; Veiga MD
    Int J Pharm; 2015 Oct; 494(1):235-43. PubMed ID: 26276258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biphasic release of indomethacin from HPMC/pectin/calcium matrix tablet: I. Characterization and mechanistic study.
    Wu B; Chen Z; Wei X; Sun N; Lu Y; Wu W
    Eur J Pharm Biopharm; 2007 Nov; 67(3):707-14. PubMed ID: 17540549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sigmoidal release of indomethacin from pectin matrix tablets: effect of in situ crosslinking by calcium cations.
    Wei X; Sun N; Wu B; Yin C; Wu W
    Int J Pharm; 2006 Aug; 318(1-2):132-8. PubMed ID: 16675173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on pectins as potential hydrogel matrices for controlled-release drug delivery.
    Sungthongjeen S; Pitaksuteepong T; Somsiri A; Sriamornsak P
    Drug Dev Ind Pharm; 1999 Dec; 25(12):1271-6. PubMed ID: 10612023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pectin from Okra (
    Boakye-Gyasi ME; Owusu FWA; Entsie P; Agbenorhevi JK; Banful BKB; Bayor MT
    ScientificWorldJournal; 2021; 2021():6672277. PubMed ID: 33531880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Swelling and erosion of pectin matrix tablets and their impact on drug release behavior.
    Sriamornsak P; Thirawong N; Weerapol Y; Nunthanid J; Sungthongjeen S
    Eur J Pharm Biopharm; 2007 Aug; 67(1):211-9. PubMed ID: 17267193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of the degree of esterification on the release characteristics of in situ gelling pectin formulations for oral sustained delivery of paracetamol.
    Miyazaki S; Murofushi H; Shimoyama T; Itoh K; Kobayashi M; Attwood D
    Pharm Dev Technol; 2013; 18(5):1259-64. PubMed ID: 22304683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of pectins of different degree of esterification on in-vitro sophoridine release of hydrophilic matrix tablets containing total alkaloids of Sophora alopecuroides].
    Zhao WC; Deng HZ; Song LJ; Huang YH; Huang DH; Yan H
    Zhongguo Zhong Yao Za Zhi; 2008 Oct; 33(19):2188-92. PubMed ID: 19166003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physicochemical and powder characteristics of various citrus pectins and their application for oral pharmaceutical tablets.
    Chomto P; Nunthanid J
    Carbohydr Polym; 2017 Oct; 174():25-31. PubMed ID: 28821065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mango peel pectin as a carrier for solid dispersions.
    Kumar S; Gupta SK
    Polim Med; 2013; 43(4):231-3. PubMed ID: 24596038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Properties of tableted high-amylose corn starch-pectin blend microparticles intended for controlled delivery of diclofenac sodium.
    Desai KG
    J Biomater Appl; 2007 Jan; 21(3):217-33. PubMed ID: 16443630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and pharmacokinetic evaluation of alginate-pectin polymeric rafts forming tablets using box behnken design.
    Abbas G; Hanif M
    Drug Dev Ind Pharm; 2018 Dec; 44(12):2026-2037. PubMed ID: 30084289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In situ gelling pectin formulations for oral drug delivery at high gastric pH.
    Itoh K; Hirayama T; Takahashi A; Kubo W; Miyazaki S; Dairaku M; Togashi M; Mikami R; Attwood D
    Int J Pharm; 2007 Apr; 335(1-2):90-96. PubMed ID: 17141988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microwave modified non-crosslinked pectin films with modulated drug release.
    Anuar NK; Wong TW; Taib MN
    Pharm Dev Technol; 2012; 17(1):110-7. PubMed ID: 20958167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immersion coating of pellets with calcium pectinate and chitosan.
    Hiorth M; Versland T; Heikkilä J; Tho I; Sande SA
    Int J Pharm; 2006 Feb; 308(1-2):25-32. PubMed ID: 16326054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An in situ crosslinked compression coat comprised of pectin and calcium chloride for colon-specific delivery of indomethacin.
    Wei X; Lu Y; Qi J; Wu B; Chen J; Xu H; Wu W
    Drug Deliv; 2015 May; 22(3):298-305. PubMed ID: 24471938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utilization of Pectin from Okra as Binding Agent in Immediate Release Tablets.
    Owusu FWA; Boakye-Gyasi ME; Entsie P; Bayor MT; Ofori-Kwakye K
    Biomed Res Int; 2021; 2021():6002286. PubMed ID: 34888384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of binary polymer system in drug release rate modulation. 2. Influence of formulation variables and hydrodynamic conditions on release kinetics.
    Kim H; Fassihi R
    J Pharm Sci; 1997 Mar; 86(3):323-8. PubMed ID: 9050800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.